Pharmaceutical Preparations
Stocks Ranked by
Market Capitalization

Filters
LLY stock icon
Eli Lilly
LLY
1
$709B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
1%
upside
35 forecasts
Learn more
JNJ stock icon
Johnson & Johnson
JNJ
2
$351B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
33%
upside
23 forecasts
Learn more
MRK stock icon
Merck
MRK
3
$317B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
7%
upside
26 forecasts
Learn more
ABBV stock icon
AbbVie
ABBV
4
$292B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
10%
upside
14 forecasts
Learn more
ABT stock icon
Abbott
ABT
5
$183B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
18%
upside
14 forecasts
Learn more
PFE stock icon
Pfizer
PFE
6
$144B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
62%
upside
18 forecasts
Learn more
VRTX stock icon
Vertex Pharmaceuticals
VRTX
7
$102B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
8%
upside
34 forecasts
Learn more
REGN stock icon
Regeneron Pharmaceuticals
REGN
8
$98.1B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
13%
upside
28 forecasts
Learn more
BMY stock icon
Bristol-Myers Squibb
BMY
9
$97.9B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
17%
upside
14 forecasts
Learn more
ZTS stock icon
Zoetis
ZTS
10
$70B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
42%
upside
8 forecasts
Learn more
ALNY stock icon
Alnylam Pharmaceuticals
ALNY
11
$18.4B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
49%
upside
26 forecasts
Learn more
BMRN stock icon
BioMarin Pharmaceuticals
BMRN
12
$17.1B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
13%
upside
13 forecasts
Learn more
TEVA
Teva Pharmaceuticals
TEVA
13
$14.5B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
11%
upside
9 forecasts
Learn more
BGNE
BeiGene
BGNE
14
$13.8B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
68%
upside
6 forecasts
Learn more
VTRS stock icon
Viatris
VTRS
15
$13.2B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
1%
downside
3 forecasts
Learn more
KRTX stock icon
Karuna Therapeutics
KRTX
16
$12.6B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Learn more
RPRX stock icon
Royalty Pharma
RPRX
17
$12.5B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
68%
upside
4 forecasts
Learn more
UTHR stock icon
United Therapeutics
UTHR
18
$11.1B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
26%
upside
8 forecasts
Learn more
SRPT stock icon
Sarepta Therapeutics
SRPT
19
$10.9B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
26%
upside
30 forecasts
Learn more
CTLT stock icon
Catalent
CTLT
20
$10.1B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
2%
upside
9 forecasts
Learn more
IMGN stock icon
Immunogen
IMGN
21
$8.72B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Learn more
ROIV stock icon
Roivant Sciences
ROIV
22
$8.35B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
62%
upside
11 forecasts
Learn more
CERE stock icon
Cerevel Therapeutics
CERE
23
$7.65B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Learn more
VKTX stock icon
Viking Therapeutics
VKTX
24
$7.13B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
49%
upside
17 forecasts
Learn more
ITCI stock icon
Intra-Cellular Therapies
ITCI
25
$7.02B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
19%
upside
21 forecasts
Learn more
CYTK stock icon
Cytokinetics
CYTK
26
$7.01B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
29%
upside
19 forecasts
Learn more
JAZZ stock icon
Jazz Pharmaceuticals
JAZZ
27
$6.81B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
78%
upside
21 forecasts
Learn more
ELAN stock icon
Elanco Animal Health
ELAN
28
$6.69B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
15%
upside
12 forecasts
Learn more
IONS stock icon
Ionis Pharmaceuticals
IONS
29
$5.95B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
44%
upside
16 forecasts
Learn more
APLS stock icon
Apellis Pharmaceuticals
APLS
30
$5.73B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
58%
upside
28 forecasts
Learn more
BPMC stock icon
Blueprint Medicines
BPMC
31
$5.44B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
1%
upside
14 forecasts
Learn more
MDGL stock icon
Madrigal Pharmaceuticals
MDGL
32
$4.66B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
53%
upside
20 forecasts
Learn more
BBIO stock icon
BridgeBio Pharma
BBIO
33
$4.6B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
99%
upside
11 forecasts
Learn more
OGN stock icon
Organon & Co
OGN
34
$4.57B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
23%
upside
4 forecasts
Learn more
ALPN stock icon
Alpine Immune Sciences
ALPN
35
$4.22B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
32%
downside
16 forecasts
Learn more
PRGO stock icon
Perrigo
PRGO
36
$4.06B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
33%
upside
4 forecasts
Learn more
NUVL stock icon
Nuvalent
NUVL
37
$4.04B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
56%
upside
7 forecasts
Learn more
ALKS stock icon
Alkermes
ALKS
38
$4.02B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
51%
upside
9 forecasts
Learn more
RYZB stock icon
RayzeBio
RYZB
39
$3.75B
Market cap
0
Funds
holding %
Analysts
bullish %
Learn more
CBAY stock icon
CymaBay Therapeutics
CBAY
40
$3.73B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Learn more
INSM stock icon
Insmed
INSM
41
$3.68B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
83%
upside
6 forecasts
Learn more
RARE stock icon
Ultragenyx Pharmaceutical
RARE
42
$3.57B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
103%
upside
14 forecasts
Learn more
BHVN stock icon
Biohaven
BHVN
43
$3.44B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
28%
upside
11 forecasts
Learn more
PBH stock icon
Prestige Consumer Healthcare
PBH
44
$3.39B
Market cap
0
Funds
holding %
Analysts
bullish %
Learn more
CRNX stock icon
Crinetics Pharmaceuticals
CRNX
45
$3.35B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
28%
upside
22 forecasts
Learn more
BHC
Bausch Health
BHC
46
$3.15B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
28%
upside
3 forecasts
Learn more
AXSM stock icon
Axsome Therapeutics
AXSM
47
$3.11B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
101%
upside
25 forecasts
Learn more
FOLD stock icon
Amicus Therapeutics
FOLD
48
$3.05B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
84%
upside
4 forecasts
Learn more
XENE stock icon
Xenon Pharmaceuticals
XENE
49
$3.04B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
44%
upside
11 forecasts
Learn more
ACAD stock icon
Acadia Pharmaceuticals
ACAD
50
$2.81B
Market cap
0
Funds
holding %
0
Analysts
bullish %
Analyst forecast
97%
upside
37 forecasts
Learn more